Dr Robert D Schaffarzick, OD | |
816 Klondyke St, Kemmerer, WY 83101-2903 | |
(307) 877-9250 | |
Not Available |
Full Name | Dr Robert D Schaffarzick |
---|---|
Gender | Male |
Speciality | Optometrist |
Location | 816 Klondyke St, Kemmerer, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235107954 | NPI | - | NPPES |
102195800 | Medicaid | WY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 136T (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert D Schaffarzick, OD 816 Klondyke St, Kemmerer, WY 83101-2903 Ph: (307) 877-9250 | Dr Robert D Schaffarzick, OD 816 Klondyke St, Kemmerer, WY 83101-2903 Ph: (307) 877-9250 |
News Archive
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the University of Michigan to evaluate bone defect repairs using human stem cells. The one-year project, beginning in March, will be funded through the proceeds of a $108,746 grant from the National Institutes of Health (NIH) under the Small Business Innovative Research Program (SBIR).
GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrierĀ® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).
A new study predicts that when e-cigarettes are available as alternative to cigarettes, by 2050 the 32% of smokers in the UK that otherwise would have continued smoking would have completely switched to e-cigarettes.
The high and sharply fluctuating death rates in Russia are due mainly to alcohol, particularly vodka, a new prospective study of 151 000 adults confirms.
Results of a UK study published online suggest that the widely practised approach of isolating intensive-care patients infected with MRSA does not reduce cross-infection. Authors of the study caution that this finding should not be extended to general hospital wards, and needs further confirmation from larger studies.
› Verified 1 days ago